Development of potent thrombin receptor antagonist peptides

Journal of Medicinal Chemistry

Volumn 39, Issue 25, 1996, Pages 4879-4887

  Bernatowicz, Michael S ^a   Klimas, Clifford E ^a   Hartl, Karen S ^a   Peluso, Marianne ^a   Allegretto, Nick J ^a   Seiler, Steven M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMS 197525; BMS 200261; BMS 200661; CALCIUM ION; THROMBIN; THROMBIN RECEPTOR; THROMBIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; NONHUMAN; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOSIS;

ANIMALS; DRUG DESIGN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; PEPTIDES; RECEPTORS, THROMBIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029758276     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960455s     Document Type: Article

References (37)

1. Vu, T.-K. H.; Hung, D. T.; Wheaton, V. I.; Coughlin, S. R. Molecular Cloning of a Functional Thrombin Receptor Reveals a Novel Proteolytic Mechanism of Receptor Activation. Cell 1991, 64, 1057-1068.
2. Schwartz, T. W. Locating Ligand-binding Sites in 7TM Receptors by Protein Engineering. Current Opin. Biotechnol. 1994, 5, 434-444.
3. Scarborough, R. M.; Naughton, M. A.; Teng, W.; Hung, D. T.; Rose, J. W.; Vu, T.-K. H.; Wheaton, V. I.; Turck, C. W.; Coughlin, S. R. Tethered Ligand Agonist Peptides. Structural Requirements for Thrombin Receptor Activation Reveal Mechanism of Proteolytic Unmasking of Agonist Function. J. Biol. Chem. 1992, 267, 13146-13149.
4. For reviews, see: (a) Ogletree, M. L.; Natarajan, S.; Seiler, S. M. Thrombin Receptors as Drug Discovery Targets. Perspect. Drug Discovery Des. 1994, 1, 527-536. (b) Coughlin, S. R. Thrombin Receptor Function and Cardiovascular Disease. Trends Cardiovasc. Med. 1994, 4, 77-83. (c) Seiler, S. M. Thrombin Receptor Antagonists. Sem. Hemostasis Thromb. 1996, 22, in press.
5. For reviews, see: (a) Ogletree, M. L.; Natarajan, S.; Seiler, S. M. Thrombin Receptors as Drug Discovery Targets. Perspect. Drug Discovery Des. 1994, 1, 527-536. (b) Coughlin, S. R. Thrombin Receptor Function and Cardiovascular Disease. Trends Cardiovasc. Med. 1994, 4, 77-83. (c) Seiler, S. M. Thrombin Receptor Antagonists. Sem. Hemostasis Thromb. 1996, 22, in press.
6. For reviews, see: (a) Ogletree, M. L.; Natarajan, S.; Seiler, S. M. Thrombin Receptors as Drug Discovery Targets. Perspect. Drug Discovery Des. 1994, 1, 527-536. (b) Coughlin, S. R. Thrombin Receptor Function and Cardiovascular Disease. Trends Cardiovasc. Med. 1994, 4, 77-83. (c) Seiler, S. M. Thrombin Receptor Antagonists. Sem. Hemostasis Thromb. 1996, 22, in press.
7. 2+ Mobilization. FEBS Lett, 1991, 288, 123-128.
8. Bahou, W. F.; Coller, B. S.; Potter, C. L.; Norton, K. J.; Kutok, J. L.; Goligorsky, M. S. The Thrombin Receptor Extracellular Domain Contains Sites Crutial for Peptide Ligand-induced Activation. J. Clin. Invest. 1993, 91, 1405-1413.
9. Zhong, C.; Hayzer, D. J.; Corson, M. A.; Runge, M. S. Molecular Cloning of the Rat Vascular Smooth Muscle Thrombin Receptor: Evidence for in vivo Regulation by Basic Fibroblast Growth Factor. J. Biol. Chem. 1992, 267, 16975-16979.
10. Ngaiza, J. R.; Jaffe, E. A. A 14 Amino Acid Peptide Derived from the Amino Terminus of the Cleaved Thrombin Receptor Elevates Intracellular Calcium and Stimulates Prostacyclin Production in Human Endothelial Cells. Biochem. Biophys. Res. Commun. 1991, 179, 1656-1661.
11. McNamara, C. A.; Sarembock, I. J.; Gimple, L. W.; Fenton, J. W. I.; Coughlin, S. R.; Owens, G. K. Thrombin Stimulates Proliferation of Cultured Rat Aortic Smooth Muscle Cells by a Proteolytically Activated Receptor. J. Clin. Invest. 1993, 91, 94-98.
12. Glembotski, C. C.; Irons, C. E.; Krown, K. A.; Murray, S. F.; Sprenkle, A. B.; Sei, C. A. Myocardial Alpha-Thrombin Receptor Activation Induces Hypertrophy and Increases Atrial Natriutic Factor Gene Expression. J. Biol. Chem. 1993, 268, 20646-20652.
13. Park, T. H.; McHowat, J.; Wolf, R. A.; Corr, P. B. Increased Lysophosphatidylcholine Content Induced by Thrombin Receptor Stimulation in Adult Rabbit Cardiac Ventricular Myocytes. Cardiovasc. Res. 1994, 28, 1263-1268.
14. Scarborough, R. M. Thrombin Receptor Antagonists. Int. Patent Application WO9403479-A1, 1994.
15. Scarborough, R.; Teng, W.; Naughton, M. A.; Rose, J. W.; Alves, V.; Arfsten, A. A Thrombin Receptor Antagonist Designed From Tethered Ligand Agonist Peptides. Circulation 1992, 86, I-151.
16. Lindahl, A. H.; Scarborough, R. M.; Naughton, M. A.; Harker, L. A.; Hanson, S. R. Antithrombotic Effect of a Thrombin Antagonist Peptide in Baboons. Thromb. Haemostasis 1993, 69, 1196.
17. Vassallo, R. R., Jr.; Kieber-Emmons, T.; Cichowski, K.; Brass, L. F. Structure-Function Relationships in the Activation of Platelet Thrombin Receptors by Receptor-Derived Peptides. J. Biol. Chem. 1892, 267, 6081-6085.
18. Hui, K. Y.; Jakubowski, J. A.; Wyss, V. L.; Angleton, E. L. Minimal Sequence Requirement of Thrombin Receptor Agonist Peptide. Biochem. Biophys. Res. Commun. 1992, 184, 790-796.
19. Chao, B. H.; Kalkunte, S.; Maraganore, J. M.; Stone, S. R. Essential Groups in Synthetic Agonist Peptides for Activation of the Platelet Thrombin Receptor. Biochemistry 1992, 31, 6175-6178.
20. Sabo, T.; Gurwitz, D.; Motola, L.; Brodt, P.; Barak, R.; Elhanaty, E. Structure-Activity Studies of the Thrombin Receptor Activating Peptide. Biochem. Biophys. Res. Commun. 1992, 188, 604-610.
21. Van Obberghen-Schilling, E.; Rasmussen, U. B.; Vouret-Craviari, V.; Lentes, K. U.; Pavirani, A.; Pouysségur, J. Structure-Activity Analysis of Synthetic Alpha-Thrombin-Receptor-Activating Peptides. Biochem. J. 1993, 292, 667-671.
22. Nose, T.; Shimohigashi, Y.; Ohno, M.; Costa, T.; Shimizu, N.; Ogino, Y. Enhancement of Thrombin Receptor Activation by Thrombin Receptor-Derived Heptapeptide with para-Fluorophenylalanine in Place of Phenylalanine. Biochem. Biophys. Res. Commun. 1993, 193, 694-699.
23. Natarajan, S.; Riexinger, D.; Gamberdella, M.; Seiler, S. "Tethered Ligand" Derived Pentapeptide Agonists of Thrombin Receptor: A Study of Side Chain Requirements for Platelet Activation. Int. J. Pept. Protein Res. 1995, 45, 145-151.
24. Feng, D.-M.; Veber, D. F.; Connolly, T. M.; Condra, C.; Tang, M.-J.; Nutt, R. F. Development of a Potent Thrombin Receptor Ligand. J. Med. Chem. 1995, 38, 4125-4130.
25. Seiler, S. M.; Peluso, M.; Tuttle, J. G.; Pryor, K.; Klimas, C.; Matsueda, G. R.; Bernatowicz, M. S. Thrombin Receptor Activation By Thrombin And Receptor-Derived Peptides In Platelet and CHRF-288 Cell Membranes: Receptor-Stimulated GTPase and Evaluation of Agonists and Partial Agonists. Mol. Pharmacol. 1996, 49, 190-197.
26. 82-89 Domain Activate the Receptor and Block Agonist Peptide Binding. Manuscript submitted for publication.
27. Balasubramanian, N.; St. Laurent, D. R.; Federici, M. E.; Meanwell, N. A.; Wright, J. J.; Schumacher, W. A.; Seiler, S. M. Active Site-Directed Synthetic Thrombin Inhibitors: Synthesis, In Vitro and In Vivo Activity Profile of BMY44621 and Analogs. An Examination of the Role of the Amino Group in the D-Phe-Pro-Arg-H Series. J. Med. Chem. 1993, 36, 300-303.
28. Bernatowicz, M. S.; Wu, Y.; Matsueda, G. R. Urethane Protected Derivatives of 1-Guanylpyrazole for the Mild and Efficient Preparation of Guanidines. Tetrahedron Lett. 1993, 34, 3389-3392.
29. Bernatowicz, M. S.; Matsueda, G. R. Synthesis of Peptides Containing p-Guanidinophenylalanine. In Peptides 1994. Proceedings of the 23rd European Peptide Symposium; Maia, H. L. S., Ed.; ESCOM: Leiden, The Netherlands, 1995; pp 759-760.
30. Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Reactifs de Couplage Peptidique IV. (1)-l'Hexafluorophosphate de Benzotriazolyl N-Oxytrisdimethylamino Phosphonium (B. O. P.). (Peptide Coupling Reagents IV. (1H-benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (B.O.P.).) Tetrahedron Lett. 1975, 1219-1222.
31. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color Test for Detection of Free Terminal Amino Groups in the Solidphase Synthesis of Peptides. Anal. Biochem. 1970, 34, 595-598.
32. Bernatowicz, M. S.; Wu, Y.; Matsueda, G. R. 1H-Pyrazole-1-carboxamidine Hydrochloride: An Attractive Reagent for Guanylation of Amines and its Application to Peptide Synthesis. J. Org. Chem. 1992, 57, 2497-2502.
33. Story, S. C.; Aldrich, J. V. Side-product Formation During Cyclization with HBTU on a Solid Support. Int. J. Pept. Protein Res. 1994, 43, 292-296.
34. Chao, H.-G.; Bernatowicz, M. S.; Reiss, P. D.; Klimas, C. E.; Matsueda, G. R. A Novel and Versatile Silicon-derived Linkage Agent, 4-[1-Hydroxy-2-(trimethylsilyl)ethyl]benzoic Acid, Compatible with the Fmoc/t-Bu Strategy for Solid-phase Synthesis of C-terminal Peptide Acids. J. Am. Chem. Soc. 1994, 116, 1746-1752.
35. Liu, T.-Y.; Boykins, R. A. Hydrolysis of Proteins and Peptides in a Hermetically Sealed Microcapillary Tube: High Recovery of Labile Amino Acids. Anal. Biochem. 1989, 182, 383-387.
36. Heinrickson, R. L.; Meredith, S. C. Amino Acid Analysis by Reverse-phase High Performance Liquid Chromatography: Precolumn Derivatization with Phenylisothiocyanate. Anal. Bichem. 1984, 136, 65-74.
37. + Exchange by a Thrombin Receptor Antagonist. Biochem. Pharmacol. 1995, 49, 519-528.